Skip to main content

Global Autoinjector Market Size, Application Benefits, Global Industry Share and Trend AnalysiS

Global Autoinjector Market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen their market position. For instance, in June 2018, AbbVie, Inc. and Eisai Co., Ltd. launched HUMIRA pen, an autoinjector formulation for fully human anti-TNF- α monoclonal antibody.
Global Autoinjectors Market is expected to register a CAGR of 17.42% to reach USD 79,741 Million by 2024.
Some of the key players in the global autoinjector market are AbbVie, Inc., Eli Lily and Company, Ypsomed, Amgen, Inc., Becton, Dickinson and Company, Owen Mumford, Consort Medical, Unilife Corporation, SHL Group (Scandinavian Health Limited), Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Antares Pharma, Novartis International AG, and Bayer AG.
Avail Sample Copy for this Report Before Purchase: https://www.marketresearchfuture.com/sample_request/6311
The global autoinjectors market has been segmented into type, therapy, and distribution channel.
The market, on the basis of type, has been segmented into disposable autoinjectors and reusable autoinjectors.
The market, by therapy, has been segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others.
The market, by distribution channel, has been segmented into retail pharmacies, hospital pharmacies, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The autoinjectors market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European autoinjectors market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The autoinjectors market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The autoinjectors market in the Middle East and Africa has been segmented into the Middle East and Africa.
Regional Analysis
The market in the Americas is expected to dominate the global autoinjectors market during the forecast period owing to the presence of a well-established healthcare system, increasing healthcare expenditure, and growing prevalence of chronic diseases such as diabetes and cancer. According to the National Diabetes Statistics Report 2017, an estimated 30.3 million people of all ages had diabetes in the US in 2015.
The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with the rising prevalence of various chronic diseases.
Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing disposable income, increasing incidence of several diseases, and favorable government initiatives for healthcare facilities. The market in the Middle East and Africa is likely to account for the smallest share of the global autoinjectors market.
The market growth in this region can be attributed to the growing expenditure for the healthcare sector and developing healthcare infrastructure.
Browse Complete 108  Pages Premium Research Report Enabled with 121 Respective Tables and Figures at: https://www.marketresearchfuture.com/reports/autoinjectors-market-6311  
For instance, in September 2016, Bayer AG received the US Food and Drug Administration (FDA) approval for its electronic autoinjector BETACONNECT for the multiple sclerosis therapy. In addition, in May 2017, the company announced the approval by the US Food and Drug Administration (FDA) for myBETAapp and the BETACONNECT Navigator. With this software, people using the electronic BETACONNECT autoinjector to administer BETASERON (interferon beta-1b) can use the Bluetooth technology to connect their current autoinjector to the new myBETAapp on their mobile device or computer.
Moreover, a favorable reimbursement scenario and the availability of generic versions of autoinjectors boost the growth of the market. However, stringent government regulations for product approval and growing preference for alternative drug delivery modes such as nasal sprays may hamper the market growth during the assessment period.
Global Autoinjectors Market, by Region
  • Americas
    • North America
      • US
      • Canada
    • Latin America
  • Europe
    • Western Europe
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Rest of Western Europe
    • Eastern Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Middle East
    • Africa
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more